Eterus Capital

Eterus runs a dual strategy of growth equity and restructuring. Publicly disclosed investments include early-stage backing of Sygic, a Slovak navigation software company, a growth-round participation in the virtual-events platform HOPIN, and a restructuring position in Saneca Pharmaceuticals, a Slovak generics manufacturer. The firm's own description lists both growth and restructuring as its core strategies (per firm website).

Eterus operates primarily from Bratislava, with a portfolio that concentrates on Slovakia and the broader Central and Eastern European region. Its disclosed investments also include US-based companies such as GroupSolver, a survey-analytics firm, and the globally-recognized platform HOPIN, indicating some capacity for selective cross-border deals.

Eterus identifies as a private equity firm rather than a single family office. The origin of its capital is not publicly disclosed. Its legal and operating structure — an asset manager deploying a single mandate across multiple portfolio companies — aligns with an independent or principal-led private equity firm rather than a family office.

The firm's website states it has deployed more than €40 million across over 20 companies since inception. It does not disclose current assets under management, headcount, or fund structure. The Bratislava office is its only listed location. The disclosed deployment figure suggests a small-to-mid-market private equity platform (per firm website).

The firm does not publicly describe its fund structure, investment-vehicle preferences, or co-investment policies. The portfolio spans direct equity positions in operating companies across growth and restructuring stages, but no information is available on whether Eterus uses commingled funds, deal-by-deal SPVs, or committed discretionary capital.